Adage Capital Partners’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-500,000
| Closed | -$3.87M | – | 923 |
|
2024
Q4 | $3.87M | Buy |
+500,000
| New | +$3.87M | 0.01% | 740 |
|
2024
Q2 | – | Sell |
-165,073
| Closed | -$3.48M | – | 929 |
|
2024
Q1 | $3.48M | Buy |
+165,073
| New | +$3.48M | 0.01% | 734 |
|
2018
Q3 | – | Sell |
-300,000
| Closed | -$21.5M | – | 752 |
|
2018
Q2 | $21.5M | Sell |
300,000
-300,000
| -50% | -$21.5M | 0.05% | 382 |
|
2018
Q1 | $17.9M | Buy |
600,000
+175,000
| +41% | +$5.22M | 0.04% | 426 |
|
2017
Q4 | $14.1M | Sell |
425,000
-50,000
| -11% | -$1.66M | 0.03% | 504 |
|
2017
Q3 | $15.7M | Buy |
475,000
+150,000
| +46% | +$4.94M | 0.04% | 468 |
|
2017
Q2 | $6.42M | Hold |
325,000
| – | – | 0.02% | 613 |
|
2017
Q1 | $6.27M | Sell |
325,000
-25,000
| -7% | -$483K | 0.02% | 591 |
|
2016
Q4 | $6.49M | Buy |
350,000
+175,000
| +100% | +$3.25M | 0.02% | 584 |
|
2016
Q3 | $2.45M | Buy |
175,000
+125,000
| +250% | +$1.75M | 0.01% | 642 |
|
2016
Q2 | $400K | Hold |
50,000
| – | – | ﹤0.01% | 671 |
|
2016
Q1 | $540K | Hold |
50,000
| – | – | ﹤0.01% | 673 |
|
2015
Q4 | $830K | Sell |
50,000
-25,000
| -33% | -$415K | ﹤0.01% | 665 |
|
2015
Q3 | $1.65M | Buy |
+75,000
| New | +$1.65M | ﹤0.01% | 681 |
|